The Genetics of Age-Related Macular Degeneration: A Review of Progress to Date

Survey of Ophthalmology

Volumn 51, Issue 4, 2006, Pages 316-363

  Haddad, Stephen ^a   Chen, Clara A ^b   Santangelo, Susan L ^a,c,d   Seddon, Johanna M ^b,c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Epidemiology Unit   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

age related macular degeneration (AMD); age related maculopathy (ARM); genetics; heritability; linkage; macula; retina

Indexed keywords

ARTICLE; BLINDNESS; CHROMOSOME; CHROMOSOME 10Q; CHROMOSOME 1Q; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HERITABILITY; HUMAN; HUMAN GENOME; MEDICAL RESEARCH; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; VISUAL IMPAIRMENT;

DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MACULAR DEGENERATION; RISK FACTORS;

EID: 33745670172     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2006.05.001     Document Type: Article

References (138)

1. ___. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17. Arch Ophthalmol 123 (2005) 1484-1498
2. ___. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119 (2001) 1417-1436
3. ___. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: AREDS report no. 6. Am J Ophthalmol 132 (2001) 668-681
4. ___. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP). Arch Ophthalmol 117 (1999) 1329-1345
5. ___. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol 112 (1994) 500-509
6. Abecasis G.R., Yashar B.M., Zhao Y., et al. Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet 74 (2004) 482-494
7. Akimoto A., Akimoto M., Kuroiwa S., et al. Lack of association of mutations of the bestrophin gene with age-related macular degeneration in non-familial Japanese patients. Graefes Arch Clin Exp Ophthalmol 239 (2001) 66-68
8. Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 67 (2000) 487-491
9. Allikmets R., Seddon J.M., Bernstein P.S., et al. Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies. Hum Genet 104 (1999) 449-453
10. Allikmets R., Shroyer N.F., Singh N., et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 277 (1997) 1805-1807
11. Ayyagari R., Zhang K., Hutchinson A., et al. Evaluation of the ELOVL4 gene in patients with age-related macular degeneration. Ophthalmic Genet 22 (2001) 233-239
12. Baird P.N., Chu D., Guida E., et al. Association of the M55L and Q192R paraoxonase gene polymorphisms with age-related macular degeneration. Am J Ophthalmol 138 (2004) 665-666
13. Baird P.N., Guida E., Chu D.T., et al. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 45 (2004) 1311-1315
14. Baum L., Chan W.M., Li W.Y., et al. ABCA4 sequence variants in Chinese patients with age-related macular degeneration or Stargardt's disease. Ophthalmologica 217 (2003) 111-114
15. Bernstein P.S., Leppert M., Singh N., et al. Genotype-phenotype analysis of ABCR variants in macular degeneration probands and siblings. Invest Ophthalmol Vis Sci 43 (2002) 466-473
16. Bird A.C., Bressler N.M., Bressler S.B., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39 (1995) 367-374
17. Blackmore T.K., Fischetti V.A., Sadlon T.A., et al. M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H. Infect Immun 66 (1998) 1427-1431
18. Cho E., Hung S., Willett W.C., et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 73 (2001) 209-218
19. Christen W.G., Glynn R.J., Manson J.E., et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 276 (1996) 1147-1151
20. Clark A.G. The role of haplotypes in candidate gene studies. Genet Epidemiol 27 (2004) 321-333
21. Conley Y.P., Thalamuthu A., Jakobsdottir J., et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genet 14 (2005) 1991-2002
22. Cruickshanks K.J., Hamman R.F., Klein R., et al. The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy. Arch Ophthalmol 115 (1997) 242-250
23. De La Paz M.A., Guy V.K., Abou-Donia S., et al. Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration. Ophthalmology 106 (1999) 1531-1536
24. De La Paz M.A., Pericak-Vance M.A., Lennon F., et al. Exclusion of TIMP3 as a candidate locus in age-related macular degeneration. Invest Ophthalmol Vis Sci 38 (1997) 1060-1065
25. Donoso L.A., Kim D., Frost A., et al. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 51 (2006) 137-152
26. Edwards A.O., Ritter R., Abel K.J., et al. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
27. Esfandiary H., Chakravarthy U., Patterson C., et al. Association study of detoxification genes in age related macular degeneration. Br J Ophthalmol 89 (2005) 470-474
28. Faraone S.V., and Santangelo S.L. Methods in genetic epidemiology. In: Fava M., and Rosenbaum J.S. (Eds). Research Designs and Methods in Psychiatry (1992), Elsevier Science Publishers, New York 93-118
29. Fearon D.T. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc Natl Acad Sci USA 75 (1978) 1971-1975
30. Fiotti N., Pedio M., Battaglia Parodi M., et al. MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration. Genet Med 7 (2005) 272-277
31. Fisher S.A., Abecasis G.R., Yashar B.M., et al. Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet 14 (2005) 2257-2264
32. Friedman D.S., O'Colmain B.J., Muñoz B., et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (2004) 564-572
33. Fuse N., Suzuki T., Wada Y., et al. Molecular genetic analysis of ABCR gene in Japanese dry form age-related macular degeneration. Jpn J Ophthalmol 44 (2000) 245-249
34. Giannakis E., Jokiranta T.S., Male D.A., et al. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. Eur J Immunol 33 (2003) 962-969
35. Gold B., Merriam J.E., Zernant J., et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38 (2006) 458-462
36. Gotoh N., Kuroiwa S., Kikuchi T., et al. Apolipoprotein E polymorphisms in Japanese patients with polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Am J Ophthalmol 138 (2004) 567-573
37. Gottfredsdottir M.S., Sverrisson T., Musch D.C., et al. Age related macular degeneration in monozygotic twins and their spouses in Iceland. Acta Ophthalmol Scand 77 (1999) 422-425
38. Goverdhan S.V., Howell M.W., Mullins R.F., et al. Association of HLA class I and class II polymorphisms with age-related macular degeneration. Invest Ophthalmol Vis Sci 46 (2005) 1726-1734
39. Gragoudas E.S., Adamis A.P., Cunningham E.T., et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 (2004) 2805-2816
40. Grizzard S.W., Arnett D., and Haag S.L. Twin study of age-related macular degeneration. Ophthalmic Epidemiol 10 (2003) 315-322
41. Gurne D.H., Tso M.O., Edward D.P., et al. Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology 98 (1991) 602-607
42. Guymer R.H., Héon E., Lotery A.J., et al. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol 119 (2001) 745-751
43. Guymer R.H., McNeil R., Cain M., et al. Analysis of the Arg345Trp disease-associated allele of the EFEMP1 gene in individuals with early onset drusen or familial age-related macular degeneration. Clin Experiment Ophthalmol 30 (2002) 419-423
44. Hageman G.S., Anderson D.H., Johnson L.V., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102 (2005) 7227-7232
45. Haines J.L., Hauser M.A., Schmidt S., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
46. Haines J.L., Schnetz-Boutaud N., Schmidt S., et al. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci 47 (2006) 329-335
47. Hamdi H.K., Reznik J., Castellon R., et al. Alu DNA polymorphism in ACE gene is protective for age-related macular degeneration. Biochem Biophys Res Commun 295 (2002) 668-672
48. Hammond C.J., Webster A.R., Snieder H., et al. Genetic influence on early age-related maculopathy: a twin study. Ophthalmology 109 (2002) 730-736
49. Hayashi M., Merriam J.E., Klaver C.C., et al. Evaluation of the ARMD1 locus on 1q25-31 in patients with age-related maculopathy: genetic variation in laminin genes and in exon 104 of HEMICENTIN-1. Ophthalmic Genet 25 (2004) 111-119
50. Heiba I.M., Elston R.C., Klein B.E., et al. Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol 11 (1994) 51-67
51. Ikeda T., Obayashi H., Hasegawa G., et al. Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am J Ophthalmol 132 (2001) 191-195
52. Iyengar S.K., Song D., Klein B.E., et al. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet 74 (2004) 20-39
53. Jakobsdottir J., Conley Y.P., Weeks D.E., et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77 (2005) 389-407
54. Johnson L.V., and Anderson D.H. Age-related macular degeneration and the extracellular matrix. N Engl J Med 351 (2004) 320-322
55. Kenealy S.J., Schmidt S., Agarwal A., et al. Linkage analysis for age-related macular degeneration supports a gene on chromosome 10q26. Mol Vis 10 (2004) 57-61
56. Killingsworth M.C., Sarks J.P., and Sarks S.H. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 4 Pt 4 (1990) 613-621
57. Kimura K., Isashiki Y., Sonoda S., et al. Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 130 (2000) 769-773
58. Klaver C.C., Kliffen M., van Duijn C.M., et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63 (1998) 200-206
59. Klaver C.C., Wolfs R.C., Assink J.J., et al. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 116 (1998) 1646-1651
60. Klein B.E., Klein R., Lee K.E., et al. Risk of incident age-related eye diseases in people with an affected sibling: The Beaver Dam Eye Study. Am J Epidemiol 154 (2001) 207-211
61. Klein M.L., Mauldin W.M., and Stoumbos V.D. Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch Ophthalmol 112 (1994) 932-937
62. Klein M.L., Schultz D.W., Edwards A., et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol 116 (1998) 1082-1088
63. Klein R., Davis M.D., Magli Y.L., et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 98 (1991) 1128-1134
64. Klein R., Klein B.E., Jensen S.C., et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104 (1997) 7-21
65. Klein R., Klein B.E., Knudtson M.D., et al. Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy. Am J Ophthalmol 140 (2005) 35-44
66. Klein R., Klein B.E., and Linton K.L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99 (1992) 933-943
67. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
68. Krämer F., White K., Pauleikhoff D., et al. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet 8 (2000) 286-292
69. Kuehn M.H., Stone E.M., and Hageman G.S. Organization of the human IMPG2 gene and its evaluation as a candidate gene in age-related macular degeneration and other retinal degenerative disorders. Invest Ophthalmol Vis Sci 42 (2001) 3123-3129
70. Kuroiwa S., Kojima H., Kikuchi T., et al. ATP binding cassette transporter retina genotypes and age related macular degeneration: an analysis on exudative non-familial Japanese patients. Br J Ophthalmol 83 (1999) 613-615
71. Lotery A.J., Munier F.L., Fishman G.A., et al. Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci 41 (2000) 1291-1296
72. Magnusson K.P., Duan S., Sigurdsson H., et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLOS Med 3 (2006) e5
73. Majewski J., Schultz D.W., Weleber R.G., et al. Age-related macular degeneration-a genome scan in extended families. Am J Hum Genet 73 (2003) 540-550
74. Mares-Perlman J.A., Brady W.E., Klein R., et al. Dietary fat and age-related maculopathy. Arch Ophthalmol 113 (1995) 743-748
75. Meyers S.M., Greene T., and Gutman F.A. A twin study of age-related macular degeneration. Am J Ophthalmol 120 (1995) 757-766
76. Meyers S.M., and Zachary A.A. Monozygotic twins with age-related macular degeneration. Arch Ophthalmol 106 (1988) 651-653
77. Mold C., Kingzette M., and Gewurz H. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b. J Immunol 133 (1984) 882-885
78. Mullins R.F., Russell S.R., Anderson D.H., et al. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14 (2000) 835-846
79. National Advisory Eye Council 2001: Vision Research-A National Plan: 1999-2003, Vol. 1. A Report of the National Advisory Eye Council. National Institutes of Health, Bethesda, MD (NIH Publ. No. 98-4120)
80. Pang C.P., Baum L., Chan W.M., et al. The apolipoprotein E epsilon4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica 214 (2000) 289-291
81. Piguet B., Wells J.A., Palmvang I.B., et al. Age-related Bruch's membrane change: a clinical study of the relative role of heredity and environment. Br J Ophthalmol 77 (1993) 400-403
82. Reich D.E., Cargill M., Bolk S., et al. Linkage disequilibrium in the human genome. Nature 411 (2001) 199-204
83. Rivera A., Fisher S.A., Fritsche L.G., et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14 (2005) 3227-3236
84. Rivera A., White K., Stöhr H., et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet 67 (2000) 800-813
85. Rodríguez de Córdoba S., Esparza-Gordillo J., Goicoechea de Jorge E., et al. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41 (2004) 355-367
86. Santangelo S.L., Yen C.H., Haddad S., et al. A discordant sib-pair linkage analysis of age-related macular degeneration. Ophthalmic Genet 26 (2005) 61-67
87. Sauer C.G., White K., Stöhr H., et al. Evaluation of the G protein coupled receptor-75 (GPR75) in age related macular degeneration. Br J Ophthalmol 85 (2001) 969-975
88. Schick J.H., Iyengar S.K., Klein B.E., et al. A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. Am J Hum Genet 72 (2003) 1412-1424
89. Schmidt S., Haines J.L., Postel E.A., et al. Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Mol Vis 11 (2005) 941-949
90. Schmidt S., Klaver C., Saunders A., et al. A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet 23 (2002) 209-223
91. Schmidt S., Postel E.A., Agarwal A., et al. Detailed analysis of allelic variation in the ABCA4 gene in age-related maculopathy. Invest Ophthalmol Vis Sci 44 (2003) 2868-2875
92. Schmidt S., Saunders A.M., et al. Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender. Mol Vis 6 (2000) 287-293
93. Schmidt S., Scott W.K., Postel E.A., et al. Ordered subset linkage analysis supports a susceptibility locus for age-related macular degeneration on chromosome 16p12. BMC Genet 5 (2004) 18
94. Schultz D.W., Klein M.L., Humpert A., et al. Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. Arch Ophthalmol 121 (2003) 679-683
95. Schultz D.W., Klein M.L., Humpert A.J., et al. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet 12 (2003) 3315-3323
96. Seddon J.M., Afshari M.A., Sharma S., et al. Assessment of mutations in the Best macular dystrophy (VMD2) gene in patients with adult-onset foveomacular vitelliform dystrophy, age-related maculopathy, and bull's-eye maculopathy. Ophthalmology 108 (2001) 2060-2067
97. Seddon J.M., Ajani U., Sperduto R., et al. Dietary fat intake and age-related macular degeneration. Invest Ophthalmol Vis Sci 25 (1994) 2003
98. Seddon J.M., Ajani U.A., and Mitchell B.D. Familial aggregation of age-related maculopathy. Am J Ophthalmol 123 (1997) 199-206
99. Seddon J.M., Ajani U.A., Sperduto R.D., et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 272 (1994) 1413-1420
100. Seddon J.M., and Chen C. Epidemiology of age-related macular degeneration. In: Ryan S.J. (Ed). Medical Retina, Vol. 2 (2006), C.V. Mosby, St. Louis ed 4, pp 1017-27
101. Seddon J.M., Cote J., Davis N., et al. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 121 (2003) 785-792
102. Seddon J.M., Cote J., Page W.F., et al. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123 (2005) 321-327
103. Seddon J.M., Cote J., and Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol 121 (2003) 1728-1737
104. Seddon J.M., De La Paz M., Clements K., et al. No association between apolipoprotein E and advanced age-related macular degeneration. Am J Hum Gen 59 Suppl (1996) 388
105. Seddon J.M., Gensler G., Milton R.C., et al. Association between C-reactive protein and age-related macular degeneration. JAMA 291 (2004) 704-710
106. Seddon J.M., George S., Rosner B., et al. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 123 (2005) 774-782
107. Seddon J.M., Rosner B., Sperduto R.D., et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 119 (2001) 1191-1199
108. Seddon J.M., Santangelo S.L., Book K., et al. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 73 (2003) 780-790
109. Seddon J.M., Sharma S., and Adelman R.A. Evaluation of the clinical age-related maculopathy staging system (CARMS). Ophthalmology 113 (2006) 260-266
110. Seddon J.M., Willett W.C., Speizer F.E., et al. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 276 (1996) 1141-1146
111. Shastry B.S., and Trese M.T. Evaluation of the peripherin/RDS gene as a candidate gene in families with age-related macular degeneration. Ophthalmologica 213 (1999) 165-170
112. Shroyer N.F., Lewis R.A., Yatsenko A.N., et al. Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration. Hum Mol Genet 10 (2001) 2671-2678
113. Silvestri G., Johnston P.B., and Hughes A.E. Is genetic predisposition an important risk factor in age-related macular degeneration?. Eye 8 Pt 5 (1994) 564-568
114. Simonelli F., Margaglione M., Testa F., et al. Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Res 33 (2001) 325-328
115. Smith W., Mitchell P., and Leeder S.R. Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol 118 (2000) 401-404
116. Snow K.K., and Seddon J.M. Do age-related macular degeneration and cardiovascular disease share common antecedents?. Ophthalmic Epidemiol 6 (1999) 125-143
117. Sommer A., Tielsch J.M., Katz J., et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med 325 (1991) 1412-1417
118. Souied E.H., Benlian P., Amouyel P., et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 125 (1998) 353-359
119. Souied E.H., Ducroq D., Rozet J.M., et al. ABCR gene analysis in familial exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 41 (2000) 244-247
120. Souied E.H., Leveziel N., Richard F., et al. Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol Vis 11 (2005) 1135-1140
121. Stone E.M., Braun T.A., Russell S.R., et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med 351 (2004) 346-353
122. Stone E.M., Lotery A.J., Munier F.L., et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 22 (1999) 199-202
123. Stone E.M., Webster A.R., Vandenburgh K., et al. Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration. Nat Genet 20 (1998) 328-329
124. Thylefors B. A global initiative for the elimination of avoidable blindness. Am J Ophthalmol 125 (1998) 90-93
125. Tomany S.C., Wang J.J., Van Leeuwen R., et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 111 (2004) 1280-1287
126. Tuo J., Smith B.C., Bojanowski C.M., et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 18 (2004) 1297-1299
127. Webster A.R., Héon E., Lotery A.J., et al. An analysis of allelic variation in the ABCA4 gene. Invest Ophthalmol Vis Sci 42 (2001) 1179-1189
128. Weeks D.E., Conley Y.P., Mah T.S., et al. A full genome scan for age-related maculopathy. Hum Mol Genet 9 (2000) 1329-1349
129. Weeks D.E., Conley Y.P., Tsai H.J., et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet 75 (2004) 174-189
130. Weeks D.E., Conley Y.P., Tsai H.J., et al. Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. Am J Ophthalmol 132 (2001) 682-692
131. Wong T.Y., Shankar A., Klein R., et al. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study. Ophthalmology 113 (2006) 255-259
132. Zareparsi S., Branham K.E., Li M., et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 77 (2005) 149-153
133. Zareparsi S., Buraczynska M., Branham K.E., et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 14 (2005) 1449-1455
134. Zareparsi S., Reddick A.C., Branham K.E., et al. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci 45 (2004) 1306-1310
135. Zurdel J., Finckh U., Menzer G., et al. CST3 genotype associated with exudative age related macular degeneration. Br J Ophthalmol 86 (2002) 214-219
136. Sepp T., Kahn J.C., Thurlby D.A., et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci 47 (2006) 536-540
137. Schmidt A., Hauser MA., Scott W.K., et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Gen 78 (2006) 852-864
138. Seddon J.M., George S., Rosner B., and Klein M.L. CFH Gene Variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Human Heredity (2006) in press